Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Recombinant enzyme plus gene therapy: a unique combination therapy for cancer

May 31, 1999

CPMP recommends expanded approval of Temodal for brain tumor therapy

May 31, 1999

Ilex initiates clinical testing of vitamin D3 analogue

May 31, 1999

EntreMed announces sites for Endostatin phase I clinical trials

May 31, 1999

More news from ASCO: safety and pharmacokinetics of squalamine examined in phase I trials

May 28, 1999

Survival advantage for exemestane observed in phase III breast cancer trial reported at ASCO meeting

May 28, 1999

DNA ligase inhibitors with alpha-pyrone structure in development at Millennium

May 28, 1999

Alza submits NDA for Viadur prostate cancer treatment

May 28, 1999

Significant antitumor response shown in preclinical study of prostate cancer treatment

May 28, 1999

Matrix broadens phase II clinical trial program for FMdC to include colorectal cancer

May 28, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...